Vaccine News and Research

Latest Vaccine News and Research

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

In a new study, researchers analyzed the influence of multiple shots of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Wuhan strain vaccinations on the Omicron variant.

30 Aug 2022

UK survey reveals outlook of the public towards health information circulating during the 2022 monkeypox virus outbreak

In new research, researchers explored the understanding and acceptance of public health messages about the monkeypox virus (MPXV) in the United Kingdom (UK).

30 Aug 2022

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

In this interview, we speak to Morteza Sarmadi from MIT about his labs latest research that developed microparticles able to deliver self-boosting vaccines.

30 Aug 2022

Outlook towards Monkeypox vaccination in healthcare workers of France and Belgium

In a new study, researchers performed a cross-sectional study to evaluate the outlook of healthcare workers (HCWs) of France and Belgium towards Monkeypox virus (MPXV) vaccination.

30 Aug 2022

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

A new study explored the glycan shield diversity of sarbecoviruses, furthering the knowledge for developing broad-range pan-coronavirus vaccines.

30 Aug 2022

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Researchers found proof of negative repercussions of immune history in SARS-CoV-2 infection.

30 Aug 2022

mRNA COVID boosters are effective against severe Omicron for at least six months

A new study published in the journal JAMA Network Open aimed to analyze the association of the types of vaccine and their combination with the waning of protection against Omicron in residents of Singapore who were aged 30 years and above and had received at least two doses of a COVID vaccine.

30 Aug 2022

Men who have sex with men adopting protective measures against monkeypox virus

The U.S. Centers for Disease Control and Prevention (CDC) recently published the results of a survey specific to monkeypox virus (MPV) infection associated with the American Men's Internet Survey (AMIS) in the Morbidity and Mortality Weekly Report (MMWR).

29 Aug 2022

Study reveals a 'stealing' mechanism that contributes to antibody diversity

A few years ago, Professor Kathrin de la Rosa and her colleagues in the lab of the Swiss immunologist Antonio Lanzavecchia made an unusual discovery.

29 Aug 2022

IBS discussed collaboration with NIAID and St. Jude’s Children’s Research Hospital

The Institute for Basic Science recently visited the National Institutes of Health and announced its collaboration with St. Jude Children's Research Hospital in the U.S., with the aims of increasing virus research capacity and ability to respond to infectious disease outbreaks.

29 Aug 2022

COVID-19 vaccine hesitancy found to be strong among Republican voters and Black people

Vaccine hesitancy remains a public health challenge that cuts across the country as the COVID-19 pandemic drags on, but Republican voters and Black people are among the most hesitant to get the shot, according to a new Portland State University study.

29 Aug 2022

Study identifies two potential serological biomarkers of monkeypox infection

In a new study, researchers pursued two monkeypox virus (MPXV) immune targets, A35R and H3L, that could be deployed in a serological assay to identify recent MPXV cases.

29 Aug 2022

Cost concerns lead to delay in Nigeria’s HPV vaccination plan

Nigeria's latest target for introducing a life-saving vaccine against cervical cancer has been branded unrealistic by health specialists as cost concerns have yet to be addressed, leaving thousands of Nigerian women at risk.

29 Aug 2022

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Researchers investigated whether early treatment with oral antivirals prevented all-cause mortality in hospitalized patients infected with SARS-CoV-2 new variant of concern Omicron BA.2 subvariant.

29 Aug 2022

The effectiveness of nirmatrelvir in preventing severe COVID-19 outcomes during the Omicron surge

Researchers assessed the clinical efficacy of nirmatrelvir in preventing severe COVID-19 in Israel during the Omicron wave.

29 Aug 2022

Is there an association between the gut microbiome of people within different countries and the severity of COVID-19?

Researchers explored the complex relationship between the gut microbiome of people in different countries and the observed COVID-19 severity, measured as the hospitalization rate of the corresponding country.

29 Aug 2022

Preliminary study shows tecovirimat was well tolerated by patients with monkeypox

Researchers investigated the usage of tecovirimat against monkeypox infections.

29 Aug 2022

What are the clinical characteristics and complications of patients with a monkeypox infection?

Researchers described the clinical characteristics and complications of monkeypox virus infections.

29 Aug 2022

How does the maternal immune response balance SARS-CoV-2 antiviral responses with transplacental transfer of protection to the fetus?

Researchers found that in SARS-CoV-2 maternal infection, the balance between antiviral response and transplacental transfer of humoral and cellular protection relies on maternal IL-6 and IL10.

29 Aug 2022

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was associated with a reduction in the risk of death by 49% and in the incidence of hospitalization for influenza or pneumonia by 64% compared with standard-dose vaccination.

28 Aug 2022

Vaccine News and Research

Latest Vaccine News and Research

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

UK survey reveals outlook of the public towards health information circulating during the 2022 monkeypox virus outbreak

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

Outlook towards Monkeypox vaccination in healthcare workers of France and Belgium

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

mRNA COVID boosters are effective against severe Omicron for at least six months

Men who have sex with men adopting protective measures against monkeypox virus

Study reveals a 'stealing' mechanism that contributes to antibody diversity

IBS discussed collaboration with NIAID and St. Jude’s Children’s Research Hospital

COVID-19 vaccine hesitancy found to be strong among Republican voters and Black people

Study identifies two potential serological biomarkers of monkeypox infection

Cost concerns lead to delay in Nigeria’s HPV vaccination plan

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

The effectiveness of nirmatrelvir in preventing severe COVID-19 outcomes during the Omicron surge

Is there an association between the gut microbiome of people within different countries and the severity of COVID-19?

Preliminary study shows tecovirimat was well tolerated by patients with monkeypox

What are the clinical characteristics and complications of patients with a monkeypox infection?

How does the maternal immune response balance SARS-CoV-2 antiviral responses with transplacental transfer of protection to the fetus?

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in